IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
Czystowska, M, Han, J, Szczepanski, M J, Szajnik, M, Quadrini, K, Brandwein, H, Hadden, J W, Signorelli, K, Whiteside, T L
Published in Cell death and differentiation (01.05.2009)
Published in Cell death and differentiation (01.05.2009)
Get full text
Journal Article
Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytes
Marroni, M, Agrawal, M.L, Kight, K, Hallene, K.L, Hossain, M, Cucullo, L, Signorelli, K, Namura, S, Bingaman, W, Janigro, D
Published in Neuroscience (01.01.2003)
Published in Neuroscience (01.01.2003)
Get full text
Journal Article
Genomic structure of the locus associated with an insertional mutation in line 4 transgenic mice
Mark, W.H., Signorelli, K., Blum, M., Kwee, L., Lacy, E.
Published in Genomics (San Diego, Calif.) (01.05.1992)
Published in Genomics (San Diego, Calif.) (01.05.1992)
Get full text
Journal Article
IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro
Egan, James E, Quadrini, Karen J, Santiago-Schwarz, Frances, Hadden, John W, Brandwein, Harvey J, Signorelli, Kathy L
Published in Journal of immunotherapy (1997) (01.09.2007)
Published in Journal of immunotherapy (1997) (01.09.2007)
Get more information
Journal Article
The Importance of DR4Dw4 β Chain Residues 70, 71, and 86 in Peptide Binding and T Cell Recognition
Signorelli, Kathy L., Watts, Lynnetta M., Lambert, Laurie E.
Published in Cellular immunology (01.05.1995)
Published in Cellular immunology (01.05.1995)
Get full text
Journal Article